(Q45374782)

13 December 2017

title

In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine (English)

1 reference

13 December 2017

1 reference

Haifeng Song

1

1 reference

13 December 2017

Vaughan Wittman

2

1 reference

13 December 2017

Anthony Byers

3

1 reference

13 December 2017

Tenekua Tapia

4

1 reference

13 December 2017

Bin Zhou

5

1 reference

13 December 2017

William Warren

6

1 reference

13 December 2017

Penny Heaton

7

1 reference

13 December 2017

Kevin Connolly

8

1 reference

13 December 2017

language of work or name

English

0 references

publication date

25 June 2010

1 reference

13 December 2017

1 reference

13 December 2017

volume

28

1 reference

13 December 2017

issue

34

1 reference

13 December 2017

page(s)

5524-5532

1 reference

Adaptation and Growth Characteristics of Influenza Virus at 25° C

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Impact of influenza on mortality in relation to age and underlying disease, 1967-1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Antibody response to influenza vaccination in the elderly: a quantitative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Influenza neuraminidase as a vaccine antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

T cell responses are better correlates of vaccine protection in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

The unmet need in the elderly: designing new influenza vaccines for older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Ab and T cell epitopes of influenza A virus, knowledge and opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Correlates of protection: novel generations of influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Comparative analysis of six European influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

T-cell quality in memory and protection: implications for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Class I-restricted presentation of exogenous antigen acquired by Fcγ receptor-mediated endocytosis is regulated in dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Phagocytosis induces lysosome remodeling and regulated presentation of particulate antigens by activated dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

Dendritic cells require the NF-kappaB2 pathway for cross-presentation of soluble antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.044

10.1016/J.VACCINE.2010.06.044

7 January 2021

Identifiers

DOI

1 reference

release_ehd5lmskw5eptmboemhdcu3lgy

13 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ehd5lmskw5eptmboemhdcu3lgy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference